2,918
Total Claims
$458K
Drug Cost
495
Beneficiaries
$925
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
-12%
Cost per patient vs peers
$925 vs $1,054 avg
-5%
Brand preference vs peers
12.5% vs 13.1% avg
Brand vs Generic
88% generic
Brand: 364 claims · $389K
Generic: 2,554 claims · $69K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 131 | $193K |
| Sacubitril/Valsartan | 28 | $49K |
| Evolocumab | 53 | $45K |
| Rivaroxaban | 30 | $35K |
| Ticagrelor | 35 | $28K |
| Alirocumab | 16 | $14K |
| Atorvastatin Calcium | 321 | $6,512 |
| Metoprolol Succinate | 248 | $5,447 |
| Ezetimibe | 93 | $5,235 |
| Nebivolol Hcl | 17 | $4,779 |
| Rosuvastatin Calcium | 224 | $4,712 |
| Valsartan | 141 | $4,599 |
| Nebivolol Hcl | 21 | $3,331 |
| Ranolazine | 20 | $3,258 |
| Clopidogrel Bisulfate | 140 | $3,002 |
Prescribing Profile
35
Unique Drugs
$277K
Patient Profile
75
Avg Age
36%
Female
1.41
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About